Navigation Links
VIASPACE Granted US Patent
Date:3/10/2009

PASADENA, Calif., March 10 /PRNewswire-FirstCall/ -- VIASPACE Inc. (OTC Bulletin Board: VSPC) announced today that the United States Patent and Trademark Office issued patent number 7, 499,169 to VIASPACE on March 3, 2009. The patent covers detection and measurement of water vapor (humidity) in gas streams for fuel cells and exhaust streams from combustion processes such as automobiles and factory smokestacks. Inventors are Nathan Hurvitz and VIASPACE CEO Dr. Carl Kukkonen.

VIASPACE's HS-1000 humidity sensor product is now protected by this patent. The HS-1000 uses a laser to make real-time measurements of water vapor in air or other gas streams. Humidity measurements are crucial for testing and optimization of hydrogen fuel cells and the HS-1000 has been sold to leading fuel cell developers and researchers worldwide. The other major application covered by the patent is to measure humidity in the products of combustion. Gasoline or natural gas, when burned in air, produce water vapor as a combustion product. Precise measurement of the water vapor in the exhaust may be a crucial indicator of the efficiency of combustion and the effective "miles per gallon" achieved.

One international customer extensively compared the VIASPACE HS-1000 to two leading competitors and the HS-1000 won the competition. HS-1000 customers include Ballard Power Systems, 3M, US National Renewable Energy Laboratory, Tokyo Institute of Technology and a leading worldwide automobile manufacturer.

About VIASPACE (OTCBB: VSPC) -- VIASPACE was founded in 1998 and became a public company in 2005. VIASPACE focuses on clean and alternative energy including disposable fuel cell cartridges, and a proprietary fast-growing grass as a feedstock for biofuels and for animal feed. For more information, please see

SOURCE VIASPACE Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. VIASPACE Plants Biofuel & Animal Feed Grass and Signs Land Lease in China
2. Crisis Exemption Granted to Market Avipel(R) Corn Seed Treatment in Louisiana
3. Valdoxan(R) Granted Marketing Authorisation for the Treatment of Major Depressive Episodes in Europe
4. Odyssey Thera Granted U.S. Patent for Novel GPCR Assay Strategy
5. GeneNews granted U.S. patent for Chagas disease based on Sentinel Principle(TM) platform
6. BioLife Solutions Granted European Biopreservation Patent
7. ScinoPharm Granted US Patent for Novel Crystal Forms
8. Memory Pharmaceuticals Granted Extension to Comply with NASDAQ Listing Requirements
9. MonoSol Rx Granted Strategic US Patent for Thin Film Manufacturing Process
10. Autonomy(TM) Lapro-Angle(TM) Articulating Laparoscopic Instruments Granted CE Mark
11. Wyeths Motion to Overturn Punitive Damages Award Granted by Arkansas Court
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)NEW YORK, Dec. 2 Reportlinker.com announces that a new market research report is available in its catalogue: ,, Drug Discovery Technologies - A Global Update of Market Trends & Opportunities ,,
(Date:12/2/2009)COPENHAGEN, Dec. 2 The world,s first concept demonstration tires made with BioIsoprene technology, a breakthrough alternative to replace a petrochemically produced ingredient in the manufacture of
(Date:12/2/2009)CALGARY, Dec. 2 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics" or the "Company") (TSX:ONC; NASDAQ: ONCY ) announced today that in connection with its previously announced unit offering
(Date:12/2/2009)LELYSTAD, The Netherlands, December 2 Pepscan Holding NV,the Netherlands based biotechnology company focusing on protein mimicking,technology for the generation of immune therapeutics today announced
Breaking Biology Technology:Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 8Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 9The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 2The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 4Dutch Biotech Company Pepscan Appoints New CEO 2
... BOTHELL, WA, and VANCOUVER, April 9 /PRNewswire-F...Genex" or the "Company") (NASDAQ: OGXI ), announ...ences Company of the Year by LifeSciences British ...iences British Columbia to recognize a local organ... the development of British Columbia,s life scienc...
... BEIJING, April 9 /PRNewswire-Asia/ -- Sinovac...oper and provider of vaccines in China, today anno...r the three and twelve month,periods ended Decembe...ghts, -- Record full year 2008 sales increasing... Sold 6.93 million doses of Healive(R) in 2008, up...
... , , , Company Reports Quarterly Net Income of...International, Inc. (OTC Bulletin Board: CCEL) (t... established family cord blood banks, today announ...8, 2009. Consolidated revenues for the first quar... compared to approximately $4.2 million for the fi...
Other Biology Technology:OncoGenex Pharmaceuticals Named Life Sciences Company of the Year by LifeSciences British Columbia 2OncoGenex Pharmaceuticals Named Life Sciences Company of the Year by LifeSciences British Columbia 3Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 2Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 3Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 4Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 5Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 6Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 7Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 8Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 9Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 10Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 11Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 12Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 13Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 14Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 15Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 16Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 17Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 18Cryo-Cell International, Inc. Reports First Quarter 2009 Results 2Cryo-Cell International, Inc. Reports First Quarter 2009 Results 3Cryo-Cell International, Inc. Reports First Quarter 2009 Results 4
(Date:12/4/2009)By measuring the total gene activity in organs relevant for coronary artery disease (CAD), scientists at the Swedish medical university Karolinska Institutet have identified a module of genes that is
(Date:12/4/2009)Using a new mathematical model of heart cells, University of Iowa investigators have shown how activation of a critical enzyme, calmodulin kinase II (CaM kinase), disrupts the electrical activity of h
(Date:12/3/2009)Our ability to learn new information and adapt to changes in our daily environment, as well as to retain lifelong memories, appears to lie in the minute junctions where nerve cells communicate, accord
Breaking Biology News(10 mins):Scientists discover gene module underlying atherosclerosis development 2U-Iowa study helps advance heart-related research 2Lifelong memories linked to stable nerve connections 2Senate President Therese Murray Massachusetts Life Sciences Center and Howard Hughes Medical Institute Join Marine Biological Laboratory 28MBL 29 f 14185 1Senate President Therese Murray Massachusetts Life Sciences Center and Howard Hughes Medical Institute Join Marine Biological Laboratory 28MBL 29 f 14185 2Senate President Therese Murray Massachusetts Life Sciences Center and Howard Hughes Medical Institute Join Marine Biological Laboratory 28MBL 29 f 14185 3Senate President Therese Murray Massachusetts Life Sciences Center and Howard Hughes Medical Institute Join Marine Biological Laboratory 28MBL 29 f 14185 4Dr Robert Lanza Featured on Michio Kakus Explorations in Science 14184 1Dr Robert Lanza Featured on Michio Kakus Explorations in Science 14184 2Dr Robert Lanza Featured on Michio Kakus Explorations in Science 14184 3Fight Against Obesity Takes Off 21 16 Mayors and More Than 80 Cities Take Steps Toward Wellness 57810 1Fight Against Obesity Takes Off 21 16 Mayors and More Than 80 Cities Take Steps Toward Wellness 57810 2Fight Against Obesity Takes Off 21 16 Mayors and More Than 80 Cities Take Steps Toward Wellness 57810 3
...known as HACNS1, that may have contributed to the ...nd possibly also modifications in the ankle or foo... to a paper published in Science on Sept. 5, 200...of the existence of human-specific gene enhancers,.... , Dr. Shyam Prabhakar, first author of the pa...
...f Cincinnati (UC) implicates the primary chemical ... risk factor for metabolic syndrome and its conseq...n fat tissues, the UC team found that BPA suppress...e for regulating insulin sensitivity in the body a...metabolic syndrome. , Metabolic syndrome is a co...
... A variety of organismsfrom bacteria and fungi to ...he timing and duration of fundamental biological p...apt and survive, even under fluctuating environmen...nces have been made to understand the molecular ba...odifications in cellular physiology and organismal...
Other Biology News:Gene enhancer in evolution of human opposable thumb 2Gene enhancer in evolution of human opposable thumb 3Bisphenol A linked to metabolic syndrome in human tissue 2Interdisciplinary volume on biological rhythms serves as both primer and in-depth resource 2
PCASMC (P350-05) from European Collection of Cell Cultures (ECACC)
Rabbit Anti-alpha-N-Catenin Polyclonal Antibody, Unconjugated from Cell Signaling Technology
BioDoc-It System from UVP
AC1 Auto System, OptiChemi™ Camera from UVP
Biology Products: